← Back to Analyst Consensus 
HCA Hold
HCA Healthcare, Inc.
Current Price —
Implied Upside —
Analysts 31
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Oct 27, 2026 (1 day)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 23, 2026 | BMO Capital | initiate | — → Outperform | — | 53% |
| Sep 18, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Sep 8, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Aug 20, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Aug 3, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 28, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Jul 28, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 27, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jul 27, 2026 | Morgan Stanley | maintain | Underweight → Underweight | — | 54% |
| Jul 27, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Jul 27, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 27, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Jul 27, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| Jul 27, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Jul 27, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jul 16, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jul 15, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 14, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| Jul 13, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 8, 2026 | Barclays | downgrade | Overweight → Equal-Weight | — | 53% |
| Jul 7, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Jun 22, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jun 4, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| Apr 27, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 27, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 27, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Apr 27, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 27, 2026 | Stephens & Co. | maintain | Overweight → Overweight | — | 54% |
| Apr 27, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| Apr 27, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Apr 27, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Mar 10, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Feb 25, 2026 | Mizuho | maintain | Outperform → Outperform | $585 | 52% |
| Feb 23, 2026 | UBS | maintain | Buy → Buy | $635 | 54% |
| Feb 20, 2026 | JP Morgan | maintain | Neutral → Neutral | $535 | 55% |
| Feb 6, 2026 | Argus Research | maintain | Buy → Buy | $560 | 54% |
| Jan 30, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $481 | 54% |
| Jan 28, 2026 | Jefferies | maintain | Buy → Buy | $590 | 52% |
| Jan 28, 2026 | RBC Capital | maintain | Outperform → Outperform | $555 | 55% |
| Jan 28, 2026 | UBS | maintain | Buy → Buy | $598 | 54% |
| Jan 28, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $588 | 50% |
| Jan 28, 2026 | Keybanc | maintain | Overweight → Overweight | $550 | 52% |
| Jan 28, 2026 | Oppenheimer | maintain | Outperform → Outperform | $540 | 52% |
| Jan 28, 2026 | Truist Securities | maintain | Buy → Buy | $546 | 54% |
| Jan 28, 2026 | Deutsche Bank | maintain | Buy → Buy | $558 | 57% |
| Jan 28, 2026 | Barclays | maintain | Overweight → Overweight | $551 | 53% |
| Jan 7, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $452 | 54% |
| Dec 18, 2025 | Mizuho | maintain | Outperform → Outperform | $520 | 52% |
Price Target Trend
Jul 12, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days